Less than a year after taking over the reins, Biotechnology Innovation Organization (BIO) Chief Executive Officer Michelle McMurry-Heath is reorganizing the organization's leadership structure.
BIO said the new structure will provide long-term stability for the organization’s ambitious agenda. In a brief statement, McMurry-Heath said the reorganization of BIO’s leadership structure will enable the organization to have a greater focus on its key goals of advocacy, education and collaboration.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,